S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

International Journal of Biochemistry and Cell Biology

Volumn 33, Issue 7, 2001, Pages 637-668

  Donato, Rosario ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Calcium; Receptor; S100; Signaling; Structure; Target proteins

Indexed keywords

CALBINDIN; CALCIUM; CALCYCLIN; CALDESMON; CALVASCULIN; CELL SURFACE RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOCORTIN 2; MARCKS PROTEIN; NEUROMODULIN; PROFILAGGRIN; PROTEIN P53; PROTEIN P80; PROTEIN S 100; PROTEIN S 100A1; PROTEIN S 100A10; PROTEIN S 100A11; PROTEIN S 100A12; PROTEIN S 100A13; PROTEIN S 100A2; PROTEIN S 100A3; PROTEIN S 100A5; PROTEIN S 100A8; PROTEIN S 100A9; PROTEIN S 100P; PROTEIN S100B; PSORIASIN; TAU PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN;

APOPTOSIS; ASTROCYTOSIS; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SPECIFICITY; CELL SURVIVAL; CYTOSKELETON; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; INFLAMMATORY CELL; MULTIGENE FAMILY; NERVE CELL NECROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW;

ANIMALS; BLOOD COAGULATION; CALCIUM; COGNITION; CYTOSKELETON; DIMERIZATION; EF HAND MOTIFS; HUMANS; INFLAMMATION; NEOPLASMS; NERVOUS SYSTEM PHYSIOLOGY; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEINS; S100 PROTEINS;

VERTEBRATA;

EID: 0034995073     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(01)00046-2     Document Type: Review

References (283)

1. Why cells must export calcium
2. The versatility and universality of calcium signalling
3. Structure and evolution of calcium modulated proteins
4. The EF-hand, homologs and analogs
5. A soluble protein characteristic of the nervous system
6. The amino acid sequence of the S100 protein (PAP I-b protein) and its relation to the calcium binding proteins
7. The amino acid sequence of the α-subunit in bovine brain S100a protein
8. S100 antigen in normal human skin
9. Perspectives in S100 protein biology
10. The S100 protein family: History, function, and expression
11. The S100 family of EF-hand calcium-binding proteins: Functions and pathology
12. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type
13. S100 proteins
14. Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage
15. Brain S100A5 is a novel calcium-, zinc-, and copper ion-binding protein of the EF-hand superfamily
16. The S100 protein family: A biochemical and functional overview
17. The structure of human trichoyalin. Potential multiple roles as a functional EF-hand-like calcium-binding protein, a cornified cell envelope precursor, and an intermediate filament-associated (crosslinking) protein
18. Characterization of two distinct calcium-binding sites in the amino-terminus of human profilaggrin
19. Repetin (Rptn), a new member of the 'fused gene' subgroup within the S100 gene family encoding a murine epidermal differentiation protein
20. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: Rationale for a new nomenclature of the S100 calcium-binding protein family
21. Gene encoding the β subunit of S100 protein is on chromosome 21: Implications for Down's syndrome
22. Brain interleukin 1 and S100 immunoreactivity are elevated in Down's syndrome and Alzheimer disease
23. The human calbindin-D9k gene. Complete structure and implications on steroid hormone regulation
24. 2+-binding proteins
25. Solution structure of rat apo-S100B (ββ) as determined by NMR spectroscopy
26. The solution structure of the bovine S100B protein dimer in the calcium free state
27. A novel mode of target recognition suggested by the 2.0 Å structure of holo S100B from bovine brain
28. EF-hands at atomic resolution: The structure of human psoriasin (S100A7) solved by MAD phasing
29. Solution structure of calcium-bound rat S100B (ββ) as determined by NMR spectroscopy
30. 2+-signal transduction by S100 proteins
31. A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form
32. The crystal structure of a complex of p11 with the annexin II N-terminal peptide
33. 2+-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I
34. Crystallization and preliminary X-ray diffraction analysis of human calcium-binding protein S100A12
35. The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 Å resolution
36. Signal transduction versus buffering activity in calcium-binding proteins
37. High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14
38. Analysis of the MRP8-MRP14 protein-protein interaction by the two-hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation
39. Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma
40. Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1
41. The S100A6 and S100A11 are specific targets of the calcium and zinc-binding S100B proteinin vivo
42. Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system
43. Oligomerization state of S100B(ββ) at nanomolar concentration determined by large-zone analytical gel filtration chromatography
44. Assignment and secondary structure of calcium-bound human S100B
45. The regulatory chain in the p36-kd substrate complex of viral tyrosine-specific protein kinases is related in sequence to the S100 protein of glial cells
46. 2+-dependent interaction of S100B(ββ) with a peptide derived from p53
47. Identification of effector binding sites of S100β: Studies with guanylate cyclase and p80, a retinal phosphoprotein
48. 2+-bound rat S100B (ββ) upon binding to a peptide derived from the C-terminal regulatory domain of p53
49. Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization
50. Structure of the negative regulatory domain of p53 bound to S100B(ββ)
51. Recognition by calmodulin: 2.4 Å structure of a calmodulin peptide complex
52. Solution structure of a calmodulin-target peptide complex by multidimensional NMR
53. Identification of the binding site on S100B protein for the actin capping protein CapZ
54. S100A1 utilizes different mechanisms for interacting with calcium-dependent and calcium-independent target proteins
55. Replicating myoblasts and fused myotubes express the calcium-modulated proteins S100A1 and S100B
56. Characterization of S100b binding epitopes: Identification of a novel target, the actin capping protein, Cap Z
57. o binding site in CapZ α-subunit
58. Hydrophobic residues in the C-terminal extension of S100A1 are essential for target protein binding not for dimerization
59. 2+ enhancement of the S100B binding epitope TRTK-12
60. S100 (α and β)-binding peptide (TRTK-12) blocks S100/GFAP interaction: Identification of a putative S100 target epitope within the head domain of GFAP
61. 2+-dependent manner
62. Interaction of S100 protein with smooth muscle caldesmon
63. Annexin VI binds to S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments
64. 2 heterotetramer complex
65. S100A1 and S100B interactions with annexins
66. Inhibition by calmodulin of calcium/phospholipid-dependent protein phosphorylation
67. Calcium-dependent conformational changes in the 36-kDa subunit of intestinal protein I related to the cellular 36-kDa target of Rous sarcoma virus tyrosine kinase
68. Functionally distinct serine phosphorylation sites of p36, the cellular substrate of retroviral protein kinase; differential inhibition of reassociation with p11
69. Modulation of tyrosine phosphorylation of p36 and other substrates by the S100 protein
70. Comparison of S100b with calmodulin: Interactions with mellitin and microtubule-associated tau proteins by protein kinase C
71. 2+/calmodulin-dependent protein kinase II
72. Interaction of smooth muscle caldesmon with S100 protein
73. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and an S100β binding protein
74. Inhibition of protein kinase C- and casein kinase II-mediated phosphorylation of GAP-43 by S100β
75. Glial-derived S100b protein selectively inhibits recombinant β protein kinase C (PKC) phosphorylation of neuron-specific protein F1/GAP43
76. Differential responses of protein kinase C substrates (MARCKS, neuromodulin, and neurogranin) phosphorylation to calmodulin and S100
77. Purification and characterization of a novel calcium-binding protein, S100C, from porcine heart
78. Interaction of bHLH transcription factors with calcium-binding calmodulin and S100a(αα) proteins
79. Structural requirements for annexin I-S100C complex formation
80. Calcium-dependent binding of S100C to the N-terminal domain of annexin I
81. The S100B protein inhibits phosphorylation of GFAP and vimentin in a cytoskeletal fraction from immature rat hippocampus
82. Metastasis-associated 1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin
83. 1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes
84. Inhibition of norepinephrine-induced cardiac hypertrophy in S100β transgenic mice
85. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis
86. 2+-dependent S100-target protein interactions
87. Identification of a molecular target for the calcium-modulated protein S100: Fructose-1,6-bisphosphate aldolase
88. Identification of an S100 target protein: Glycogen phosphorylase
89. Identification of an S100A1/S100B target protein: Phosphoglucomutase
90. 2+/S100 regulation of giant protein kinases
91. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins
92. Activation of bovine photoreceptor guanylate cyclase by S100 proteins
93. Molecular characterization of S100A1-S100B protein in retina and its activation mechanism of bovine photoreceptor guanylate cyclase
94. Structural and functional characterization of retinal calcium-dependent guanylate cyclase activator protein (CD-GCAP): Identity with S100β protein
95. S100B and S100A1 proteins in bovine retina: Their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry
96. A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases
97. Titins: Giant proteins in charge of muscle ultrastructure and elasticity
98. Structure and function of titin and nebulin
99. ao protein: Purification by a simple procedure and related immunocytochemical and immunochemical studies
100. Analysis of S100A1, S100B and annexins V and VI in developing and adult avian skeletal muscles
101. Antisense inhibition of glial S100β production results in alteration in cell morphology, cytoskeletal organization, and cell proliferation
102. 2+-binding proteins in the retina
103. Photoreceptor guanylate cyclases: A review
104. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues
105. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues
106. 2
107. Analysis of S100A1 expression during skeletal muscle and neuronal cell differentiation
108. 2+ release from isolated sarcoplasmic reticulum vesicles
109. + release in purified sarcoplasmic reticulum vesicles of frog skeletal muscle
110. 2+ release channel (ryodanine receptor) of skeletal muscle
111. 2+-binding protein S100A1 in human cardiomyopathy
112. 2+ binding protein S100A1 in chronic pulmonary hypertension
113. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice
114. Analysis of the calcium-modulated proteins, S100 and calmodulin, and their target proteins during C6 glioma cell differentiation
115. Association of S100B with intermediate filaments and microtubules in glial cells
116. Calcium-sensitivity of brain microtubule proteins in the presence of S100 proteins
117. Calcium-independent, pH-regulated effects of S100 proteins on assembly-disassembly of brain microtubule protein in vitro
118. Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines
119. S100A1 regulates neurite organization, tubulin levels, and proliferation in PC12 cells
120. A logical sequence search for S100B target proteins
121. o, S100a, S100b) on desmin assembly in vitrol
122. 2+-dependent manner
123. Mechanism of S100 protein-dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization
124. 2 binds the rod domain
125. 2 (calpactin I) stimulates the assembly of GFAP in a calcium- and pH-dependent manner
126. Detection of S100b protein in triton-cytoskeletons: An immunocytochemical study on cultured Schwann cells
127. 2+/S100A1-interacting proteins
128. Dephosphorylated synapsin I anchors synaptic vesicles to actin cytoskeleton: An analysis by video microscopy
129. The submembranous location of p11 and its interaction with the p36 substrate of pp60src kinase in situ
130. The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: Studies using monoclonal antibodies to calpactin subunits
131. 2+-binding sites
132. Identity of p36 phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush-border; calcium-dependent binding to non-erythroid spectrin and F-actin
133. r tyrosine kinase substrate (calpactin) which interact with phospholipid and actin
134. Calcium-dependent regulation of actin filament bundling by lipocortin-85
135. 2+-dependent manner. Implications for concerted regulatory effects of calpactin I and S100 protein on glial filaments
136. 2 (calpactin I) act in concert to regulate the state of assembly of GFAP intermediate filaments in vitro
137. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid binding proteins
138. Annexins and membrane dynamics
139. The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: Studies using monoclonal antibodies to calpactin subunits
140. Annexin II tetramer: Structure and function
141. Aggregation of chromaffin granules by calpactin at micromolar levels of calcium
142. Reorganization of peripheral actin filaments as a prelude to exocytosis
143. Translocation of a small cytosolic calcium-binding protein (MRP-8) to plasma membranes correlates with human neutrophil activation
144. MRP8 and MRP14, S100-like proteins associated with myeloid differentiation, are translocated to plasma membranes and intermediate filaments in a calcium-dependent manner
145. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments
146. 2+-dependent translocation from cytoplasm to membranes and cytoskeleton
147. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway
148. Calcium-dependent control of caldesmon-actin interaction by S100 protein
149. 2+-dependent regulation of vascular smooth-muscle caldesmon by S100 and related smooth-muscle proteins
150. Characterization of the smooth muscle calponin and calmodulin complex
151. Calcium-dependent regulation of smooth muscle calponin by S100
152. Interaction of S100 protein with smooth muscle caldesmon
153. Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene
154. Interactions in vitro of p9Ka, the rat S100-related, metastasis-inducing, calcium-binding protein
155. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin
156. Interaction of metastasis associated mts1 protein with nonmuscle myosin
157. Calvasculin as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene
158. The S100-related calcium binding protein, p9Ka, and metastasis in rodent and human mammary cells
159. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium
160. 2+-dependent binding of calcyclin to muscle tropomyosin
161. Calcium-dependent regulation of caldesmon by an 11-kDa smooth muscle calcium-binding protein, caltropin
162. 2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins
163. 2+-dependent inhibition of actin-activated myosin ATPase activity by S100C (S100A11), a novel member of the S100 protein family
164. (36/32), a barbed end actin-capping protein, is a component of the Z disc of skeletal muscle
165. Effects of CapZ, an actin capping protein of muscle, on the polymerization of actin
166. Identification and characterization of an actin-binding site of CapZ
167. Inhibition of CapZ during myofribillogenesis alters assembly of actin filaments
168. Examination of the calcium-modulated protein S100α and its target proteins in adult and developing skeletal muscle
169. Basic helix-loop-helix protein sequences determining differential inhibition by calmodulin and S100 proteins
170. Expression pattern of S100 calcium-binding proteins in human tumors
171. Proteins of the brain extracellular fluid: Evidence for release of S100 protein
172. Secretion of S100 from rat C6 glioma cells
173. Novel clonal strains from adult rat anterior pituitary producing S100 protein
174. Regulation of nervous system specific S100 protein and enolase levels in adipose tissue by catecholamines
175. Disulfide-linked S100β dimers and signal transduction
176. Purification and characterization of a neurite extension factor from bovine brain
177. Neurite extension and neuronal survival activities of recombinant S100β proteins that differ in the content and position of cysteine residues
178. Neurotrophic activity of S100β in cultured dorsal root ganglia from embryonic chick and fetal rat
179. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vitro
180. S100 protein is released from astroglial cells by stimulation of 5-HT1A receptors
181. Serotoninergic sprouting into transplanted C-6 gliomas is blocked by S100β antisense gene
182. S100β protects hippocampal neurons from damage induced by glucose deprivation
183. S100β prevents the death of motor neurons in newborn rats after sciatic nerve section
184. S100β stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants
185. Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of Nerve Growth Factor and S100β protein from cultured astrocytes
186. 1A-receptor agonist, Bay x 3702
187. Neuronal survival activity of S100 ββ is enhanced by calcineurin inhibitors and requires activation of NF-κB
188. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation
189. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins
190. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
191. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system
192. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polipeptides
193. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways
194. Oligomeric forms of the metastasis related Mts1 (S100A4) protein, stimulate neuronal differentiation in cultures of rat hippocampal neurons
195. Metastasis-associated mts1 (S100A4) protein in the developing and adult central nervous system
196. Neurotrophic protein S100β stimulates glial cell proliferation
197. Extracellular S100B protein modulates ERK in astrocyte cultures
198. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
199. Brain interleukin 1 and S100 immunoreactivity are elevated in Down's syndrome and Alzheimer disease
200. Increased S100β neurotrophic activity in Alzheimer disease temporal lobe
201. S100β protein expression in Alzheimer's disease: Potential role in the pathogenesis of neuritic plaques
202. Correlation of astrocytic S100β expression with dystrophyc neurites in amyloid plaques of Alzheimer's disease
203. Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy
204. + astrocytes with neurofibrillary tangle stage
205. Selective increase in S100β protein by aging in rat cerebral cortex
206. Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease
207. Overexpression of the neurotrophic cytokine S100β precedes the appearance of neuritic β-amyloid plaques in APPV717F mice
208. Amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures
209. Chronic elevation of S100β protein does not alter APP mRNA expression or promote β-amyloid deposition in the brains of aging transgenic mice
210. S100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures
211. Cytokine regulation of neuronal survival
212. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
213. S100β induction of the proinflammatory cytokine interleukin-6 in neurons
214. The brain protein S100ab induces apoptosis in PC12 cells
215. S100β induces neuronal cell death through nitric oxide release from astrocytes
216. Bcl-2 expression regulates cell sensitivity to S100β-mediated apoptosis
217. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes
218. 2+-binding protein (S100)-dependent apoptosis in rat phaeochromocytoma cells
219. Modulation of glial activation by astrocyte-derived protein S100B: Differential responses of astrocyte and microglial cultures
220. S100B expression in and effects on microglia
221. S100 protein release in a range of cardiothoracic procedures
222. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest
223. S100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction
224. Leakage of brain-originated proteins in peripheral blood: Temporal profile and diagnostic value in early ischemic stroke
225. S100 serum levels after minor and major head injury
226. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: Prospective case-control study
227. The biology of the receptor for advanced glycation end products and its ligands
228. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)
229. S100A8: Emerging functions and regulation
230. Expression of MRP14, 27E10, interferon-α and leukocyte common antigen by reactive microglia in postmortem human brain tissue
231. Expression of the S100 proteins MRP-8 and -14 in ischemic brain lesions
232. A heterocomplex formed by the calcium-binding proteins MRP8 (S100S8) and MRP14 (S100A9) binds unsaturated fatty acids with high affinity
233. 2+-binding proteins MRP8 and MRP14 binds arachidonic acid
234. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils
235. The fatty acid-binding heterocomplex FA-p34 formed by S100A8 and S100A9 is the major fatty acid carrier in neutrophils and translocates from the cytosol to the membrane upon stimulation
236. + human monocytes
237. A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth
238. Purification of the cytotoxic factor in rat peritoneal exudate cells: Its identification as the calcium binding protein complex, calprotectin
239. Antimicrobial actions of calcium binding leukocyte L1 protein, calprotectin
240. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation
241. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis
242. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10
243. Regulation and proinflammatory properties of the chemotactic protein CP-10
244. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation
245. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8
246. Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide
247. Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli
248. IFN-γ and TNF regulate macrophage expression of the chemotactic S100 protein S100A8
249. A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo
250. Novel specific chemotactic receptor for S100L protein on guinea pig eosinophils
251. Psoriasin: A novel chemotactin protein
252. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14
253. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro
254. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family
255. Amlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fibers in vitro
256. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation
257. Functional role of the neurospecific S100 protein in the processes of memory
258. Anti-S100 serum blocks long-term potentiation in the hippocampal slice
259. Chicks injected with antisera to either S100α or S100β protein develop amnesia for a passive avoidance task
260. T-maze spontaneous alternation rate is decreases in S100β transgenic mice
261. Female transgenic mice carrying the human gene for S100β are hyperactive
262. Overexpression of a calcium-binding protein, S100β, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice
263. Nonspecific exploration in the T-maze: Abnormalities in S100β transgenic mice
264. Transgenic mice overexpressing the neurotrophic factor S100β show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disease and Down's syndrome
265. GAP-43: An intrinsic determinant of neuronal development and plasticity
266. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
267. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells
268. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis
269. Expression of the calcium-binding protein S100S4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours
270. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells
271. The S100-related calcium-binding protein, p9Ka, and metastasis in rodent and human mammary cells
272. Phosphorylation of vertebrate nonmuscle and smooth muscle myosin heavy chains and light chains
273. Phospholipid binding, phosphorylation by protein kinase C, and filament assembly of the COOH terminal heavy chain fragments of nonmuscle myosin II isoforms MIIA and MIIB
274. Characterization of a positive regulatory element in the mts1 gene
275. Induction of S100A4 gene expression inhibits in vitro invasiveness of human squamous cell carcinoma, KOSC-3 cells
276. Down-regulation of a member of the S100 gene family in mammary carcioma cells and re-expression by azadeoxycytidine treatment
277. Positive selection of candidate suppressor genes by subtractive hybridization
278. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation
279. Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family
280. Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts
281. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes
282. Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales
283. Genomic structure, promoter characterization and mutational analysis of the S100A7 gene: Exclusion of a candidate for familial psoriasis susceptibility